Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?

E-ISSN： 1873-5576|18|2|139-152

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.2, 2018-01, pp. : 139-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy in Epilepsy: When and What to Use

By Kwan Patrick

Drugs, Vol. 66, Iss. 14, 2006-01 ,pp. : 1817-1829

Adis International

Access to resources Recommend Favorite

Aptamer-Mediated Cancer Gene Therapy

Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. : 109-119

Bentham Science Publishers

Access to resources Recommend Favorite

Combination therapy a major advance in gastric cancer

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc Gligorov Joseph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab-based combination therapy for breast cancer

By Montemurro Filippo Valabrega Giorgio Aglietta Massimo

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 81-96

Informa Healthcare

Access to resources Recommend Favorite